Withdrawal of statins increases event rates in patients with acute coronary syndromes.
about
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive ratsPhysiology and pharmacology of myocardial preconditioning and postconditioning.Patients who discontinued statin treatment: a protocol for cohort study using primary care data.Statins and delirium during critical illness: a multicenter, prospective cohort study.Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation: an observational study.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionUse of ultra high performance liquid chromatography-tandem mass spectrometry to demonstrate decreased serum statin levels after extracorporeal LDL-cholesterol elimination.Update on the efficacy of statin treatment in acute coronary syndromes.Discontinuity of chronic medications in patients discharged from the intensive care unitDiscontinuation of statins in routine care settings: a cohort study.Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomesRenin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management.Early statin therapy for acute coronary syndromes.Reasons for discontinuation of lipid-lowering medications in patients with chronic kidney disease.Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients.Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process.Beyond lipid-lowering: effects of statins on endothelial nitric oxide.The importance of in-hospital statin therapy for patients with acute coronary syndromes.Association of vitamin D and incident statin induced myalgia--a retrospective cohort studyMedicine partnerships.A safety look at currently available statins.Isoprenoid metabolism and the pleiotropic effects of statinsStatins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically illDrug discontinuation effects are part of the pharmacology of a drugStatins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort studyConceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention.CD40 ligand: a novel target in the fight against cardiovascular disease.Should standard medical therapy for angina include a statin?Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.Statin use and the risk of Clostridium difficile in academic medical centres.Statin withdrawal beyond acute phase affected outcome of thrombolytic stroke patients: an observational retrospective study.Statin use and postoperative atrial fibrillation after major noncardiac surgeryStatin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease.Hypercholesterolemia: its impact on ischemia-reperfusion injury.Platelets, inflammation, and atherothrombotic neurovascular disease: the role of endothelial dysfunction.Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage.Statins in the critically ill
P2860
Q24806340-1D300161-5CB3-4305-9186-06AF2841103DQ28582463-FD9A5601-5B61-4A88-BA28-89B73D6F7F49Q30448088-5DD7E7EC-B7CB-40AD-AEE7-4197D9F6980AQ31009895-4CB1DC77-8262-4EC3-BABE-AEDE8064D3D8Q33921904-F54FA7AB-87A6-4F3E-BB5B-BA1EE9712A8DQ34081786-8DFC279B-8915-454A-A9F5-F2864F651419Q34088803-6032690B-9586-4874-8CCC-323A6DB98E3BQ34284716-CA741298-8312-426C-B616-F3EA6ECF39ACQ34408660-0962F83A-2A20-45E7-8CCE-88B6BAF0903FQ34558641-DB0EDC1E-7F9A-4A4E-82E3-617DD79BAB1CQ34644409-4B9C43D2-5370-404F-AA19-2E86CEA82748Q34732970-6B83F9BD-0E22-4583-95E8-F76A4F5BB439Q34847106-9B998D88-89CB-420E-A7C1-CB6B9AAEB797Q34849588-48174146-D242-4EA5-91DF-1878221C67AAQ34979669-BE89BD6F-E348-4962-8EE7-9EBBD4E9CFE0Q34985796-9211236E-B46B-4CE8-AC29-D14A28326B18Q35039580-364E4A7C-5BF4-414D-8184-BD615B1D66D5Q35058123-316C1BFF-5C54-4A70-BEA3-073DF27E4EEDQ35084723-D0CF6C4F-164D-4959-B118-48009823B84AQ35101478-B2B737B9-E3F6-4A6C-B300-FE9FF521A939Q35106382-F479B570-D1E0-46E3-AA75-E1EA5C63C07FQ35107067-8678B6A9-4EC9-4D32-AE04-9300B8B4A85AQ35194486-AA6FA5E3-4C8C-499E-BB11-31F5CEC7ED43Q35197114-4FEF9B94-012F-4D80-B379-0E62C2B56D1CQ35201872-416CEE8D-283C-4019-9C68-C8AF2AC1FA3CQ35430065-9842F3F8-D9E0-4940-8449-E314F5A93814Q35567062-BD218297-18DA-4B4D-8CE5-2D8B794C53EAQ35639538-B07B93FC-6828-4877-A4BA-B813E6F15119Q35826989-1B6B465A-B640-417E-9857-6F7ADBC37CA5Q35848866-376AB129-4C70-4E8C-91A0-EA68D3EE0B0CQ35955693-D10F18F6-6F60-449B-BD98-7AF5271C340AQ36088110-B8CED11E-0858-41E3-98E4-912841A79AF9Q36117003-1874C855-D0CF-4314-8784-D367EA0CBFFDQ36153662-23DBF2D4-9303-4E3B-B0CE-9DA88B14FBC3Q36228159-E0469105-9340-4F5D-AD67-ACA7024F900CQ36288354-17BF82A7-99E4-401C-85CD-DA2D4939F9D8Q36314857-9F827543-150A-4FF7-B5AF-45BA7461B8FAQ36331005-F9CB8406-B6EC-4CC7-9F2F-F30852C81AA1Q36349732-DBEA1BDF-89E4-4576-AA14-8E4AA5DBE4DBQ36369699-C19BF841-7988-4157-8608-73FE9E95BB7B
P2860
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
@en
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
@nl
type
label
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
@en
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
@nl
prefLabel
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
@en
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
@nl
P2093
P1433
P1476
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
@en
P2093
Christian W Hamm
Christopher Heeschen
Harvey D White
Michael Böhm
Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators
Steven Snapinn
Ulrich Laufs
P304
P356
10.1161/01.CIR.0000012530.68333.C8
P407
P577
2002-03-01T00:00:00Z